Intact Vascular CEO and president Bruce Shook found his way to the start-up world early in his Medtech career, serving in leadership roles at Abiomed, Neuro, and Neuronetics before assuming his current role.
In this Medtech Talk Podcast, Shook answers the questions:
- Why did he chose a career in Medtech?
- How did he enter the start-up world?
- What are his feelings about Medtech’s impact on neurology and the brain?
- What is Vesper?
- What’s Next for Intact Vascular?
Bruce Shook
President & CEO
Intact Vascular
Mr. Bruce Shook is a highly-experienced, medical device executive with more than 30 years of industry experience, including multiple early stage ventures focused on opportunities in cardiac surgery, cardiology, neurosurgery, psychiatry and vascular disease. He serves as Director, President and CEO for both Intact Vascular and Vesper Medical, a spinout of Intact Vascular formed in 2016. Prior to Intact Vascular and Vesper Medical, Mr. Shook was co-founder, Director, President and CEO of Neuronetics, Inc., which is a privately held medical device company that markets a non-invasive brain stimulation technology for the treatment of depression.
Previously, Mr. Shook was co-founder, Director, President and CEO at Neuron Therapeutics, a venture-backed company developing a drug/device product for the treatment of CNS disorders and President of Abiomed [NASDAQ: ABMD] where he successfully obtained PMA approval for the first, FDA-approved ventricular assist device. Mr. Shook also developed cardiac pacing and anti-arrhythmia products at Cordis Corporation.
Mr. Shook holds advanced degrees in Biomedical Engineering and Business Administration from Columbia University and the MIT Sloan School of Management, respectively. He earned a B.S. degree in Chemical Engineering from Penn State University. Mr. Shook currently serves on the Board of Directors at Venarum Medical, the Penn State Research Foundation and the Pennsylvania Biotechnology Association. He previously served as a Director at Surgiquest, Respicardia and CoTherix.
